CDR grafting and site-directed mutagenesis approach for the generation and affinity maturation of Anti-CD20 nanobody
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09684-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Mohammad Mehdi Heidari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Yazd University, Yazd, Iran. heidarimm@yazd.ac.ir. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Mutagenesis, Site-Directed, Antigens, CD20, Rituximab. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Yazd University, Yazd, Iran. heidarimm@yazd.ac.ir.
- Department of Biology, Yazd University, Yazd, Iran.
Zitieren
APA
Heidari, M. M., Shirazi, E. A., Cheraghi, S. F., Shahshahani, R., Rahnama, T., & Khatami, M. (2024). CDR grafting and site-directed mutagenesis approach for the generation and affinity maturation of Anti-CD20 nanobody. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09684-2
Vancouver
Heidari MM, Shirazi EA, Cheraghi SF, Shahshahani R, Rahnama T, Khatami M. CDR grafting and site-directed mutagenesis approach for the generation and affinity maturation of Anti-CD20 nanobody. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09684-2
BibTeX
@article{Heidari2024,
author = {Heidari, Mohammad Mehdi and Shirazi, Elham Anbar and Cheraghi, Seyedeh Fatemeh and Shahshahani, Roghayeh and Rahnama, Tina and Khatami, Mehri},
title = {CDR grafting and site-directed mutagenesis approach for the generation and affinity maturation of Anti-CD20 nanobody},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09684-2}
}
EUVIMED